SUCRALFATE ORAL

SUCRALFATE ORAL was reported 14489 times

SUCRALFATE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 159 0.5248
1 FEMALE GENITAL TRACT FISTULA 164 0.0960
2 RADICULOPATHY 166 0.0629
3 PROCTITIS 163 0.0581
4 CHRONIC SINUSITIS 151 0.0402
5 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 39 0.0367
6 ENTEROCOCCUS TEST POSITIVE 19 0.0293
7 REFLUX GASTRITIS 32 0.0266
8 NEPHROGENIC ANAEMIA 116 0.0250
9 ADENOCARCINOMA GASTRIC 23 0.0248
10 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 15 0.0234
11 HYPERPARATHYROIDISM SECONDARY 58 0.0231
12 REBOUND ACID HYPERSECRETION 68 0.0225
13 DIZZINESS EXERTIONAL 17 0.0224
14 EARLY SATIETY 41 0.0210
15 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 11 0.0210
16 VAGINAL DISCHARGE 169 0.0167
17 PEPTIC ULCER 49 0.0148
18 RESORPTION BONE INCREASED 12 0.0146
19 ORAL CANDIDIASIS 191 0.0145
20 BILIARY DYSKINESIA 23 0.0135
21 OESOPHAGEAL ULCER 52 0.0135
22 ANAEMIA OF CHRONIC DISEASE 12 0.0133
23 MACULAR DEGENERATION 151 0.0126
24 HYPOGONADISM 12 0.0119
25 IMPAIRED GASTRIC EMPTYING 150 0.0110
26 GALLBLADDER INJURY 19 0.0097
27 PARAESTHESIA ORAL 137 0.0095
28 END STAGE RENAL DISEASE 172 0.0094
29 GASTROINTESTINAL HYPOMOTILITY 21 0.0093
30 CREPITATIONS 27 0.0091
31 VASCULAR RUPTURE 14 0.0090
32 CHRONIC KIDNEY DISEASE 669 0.0088
33 TENDON INJURY 32 0.0086
34 OESOPHAGEAL PAIN 33 0.0083
35 VERTIGO POSITIONAL 14 0.0080
36 GASTRIC ULCER 150 0.0079
37 OESOPHAGITIS 83 0.0076
38 INFUSION SITE DISCHARGE 13 0.0074
39 FREQUENT BOWEL MOVEMENTS 200 0.0074
40 SPUTUM INCREASED 16 0.0074
41 LEUKOCYTOCLASTIC VASCULITIS 12 0.0074
42 BLOOD CHLORIDE DECREASED 19 0.0074
43 SYNOVIAL CYST 34 0.0074
44 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 11 0.0072
45 GASTRIC POLYPS 16 0.0071
46 BLOOD LOSS ANAEMIA 16 0.0071
47 CHOLECYSTITIS CHRONIC 46 0.0069
48 LIMB MASS 15 0.0068
49 CLOSTRIDIUM TEST POSITIVE 15 0.0068
50 GASTRITIS 178 0.0068
51 OESOPHAGEAL STENOSIS 19 0.0067
52 DUODENAL ULCER HAEMORRHAGE 19 0.0066
53 EROSIVE OESOPHAGITIS 11 0.0065
54 INFUSION SITE BRUISING 14 0.0065
55 BLOOD PRESSURE DIASTOLIC ABNORMAL 16 0.0063
56 ULCER HAEMORRHAGE 42 0.0062
57 BLOOD IMMUNOGLOBULIN E INCREASED 15 0.0062
58 ESSENTIAL HYPERTENSION 11 0.0060
59 SHOULDER ARTHROPLASTY 16 0.0059
60 COLITIS 225 0.0059
61 RECTAL HAEMORRHAGE 249 0.0058
62 GASTRITIS EROSIVE 27 0.0058
63 THROMBOPHLEBITIS SUPERFICIAL 17 0.0056
64 HIATUS HERNIA 72 0.0056
65 VITREOUS DETACHMENT 12 0.0055
66 OESOPHAGEAL VARICES HAEMORRHAGE 12 0.0055
67 GASTROOESOPHAGEAL REFLUX DISEASE 437 0.0054
68 GASTRIC ULCER HAEMORRHAGE 30 0.0054
69 GASTROINTESTINAL ULCER 12 0.0054
70 CHRONIC GASTRITIS 12 0.0053
71 PROCEDURAL PAIN 145 0.0052
72 BLOOD PRESSURE DIASTOLIC INCREASED 24 0.0052
73 OESOPHAGEAL DISORDER 20 0.0052
74 GASTROINTESTINAL NECROSIS 15 0.0051
75 RENAL INJURY 151 0.0051
76 DUODENITIS 15 0.0049
77 HAEMATOCHEZIA 265 0.0048
78 GASTRIC PERFORATION 13 0.0048
79 INFUSION SITE PRURITUS 15 0.0047
80 BRONCHIECTASIS 32 0.0047
81 CAROTID ARTERY STENOSIS 16 0.0046
82 CYTOLYTIC HEPATITIS 15 0.0045
83 BLOOD PRESSURE SYSTOLIC ABNORMAL 11 0.0044
84 INFUSION SITE SWELLING 28 0.0044
85 RHINALGIA 12 0.0044
86 ECONOMIC PROBLEM 66 0.0044
87 PLEURITIC PAIN 12 0.0043
88 ULCER 69 0.0043
89 VITAMIN D DEFICIENCY 42 0.0043
90 RALES 25 0.0043
91 BLOOD IRON DECREASED 51 0.0043
92 ANAL HAEMORRHAGE 12 0.0043
93 COLITIS ULCERATIVE 191 0.0043
94 MALNUTRITION 47 0.0042
95 RENAL TUBULAR NECROSIS 41 0.0042
96 ESCHERICHIA INFECTION 34 0.0041
97 MOUTH HAEMORRHAGE 30 0.0041
98 GASTRIC HAEMORRHAGE 47 0.0041
99 BLOOD MAGNESIUM DECREASED 35 0.0041
100 OESOPHAGEAL CANDIDIASIS 16 0.0040
101 IRON DEFICIENCY 18 0.0040
102 METABOLIC ENCEPHALOPATHY 12 0.0040
103 RENAL FAILURE 527 0.0040
104 UPPER GASTROINTESTINAL HAEMORRHAGE 66 0.0039
105 IRON DEFICIENCY ANAEMIA 36 0.0039
106 RED CELL DISTRIBUTION WIDTH INCREASED 16 0.0038
107 EPIGASTRIC DISCOMFORT 15 0.0038
108 FIBULA FRACTURE 11 0.0038
109 ABDOMINAL ADHESIONS 12 0.0038
110 APHTHOUS ULCER 29 0.0037
111 ODYNOPHAGIA 22 0.0037
112 SMALL INTESTINAL OBSTRUCTION 45 0.0037
113 INFUSION SITE HAEMORRHAGE 12 0.0036
114 DYSPEPSIA 355 0.0036
115 SCOLIOSIS 22 0.0035
116 PNEUMONIA FUNGAL 14 0.0035
117 DYSLIPIDAEMIA 18 0.0035
118 NEPHROPATHY 33 0.0035
119 INTERVERTEBRAL DISC DEGENERATION 32 0.0035
120 INTERNATIONAL NORMALISED RATIO DECREASED 14 0.0035
121 APLASTIC ANAEMIA 18 0.0034
122 ANAL INCONTINENCE 31 0.0034
123 HAEMATEMESIS 86 0.0034
124 THYROID MASS 13 0.0034
125 MACULOPATHY 12 0.0034
126 PRE-EXISTING CONDITION IMPROVED 21 0.0034
127 ILEUS PARALYTIC 15 0.0034
128 ACUTE KIDNEY INJURY 507 0.0033
129 ILEUS 41 0.0033
130 MUCOSAL INFLAMMATION 86 0.0033
131 INFUSION SITE PAIN 42 0.0033
132 BLOOD PRESSURE DIASTOLIC DECREASED 24 0.0032
133 DIABETIC NEUROPATHY 16 0.0032
134 MUCOUS STOOLS 16 0.0032
135 OSTEOPENIA 49 0.0032
136 DIVERTICULUM INTESTINAL 14 0.0032
137 VEIN DISORDER 16 0.0032
138 PULMONARY HAEMORRHAGE 25 0.0032
139 MELAENA 70 0.0032
140 OSTEOARTHRITIS 134 0.0032
141 AORTIC STENOSIS 11 0.0032
142 DUODENAL ULCER 22 0.0031
143 ENTEROCOCCAL INFECTION 15 0.0031
144 RHINITIS 25 0.0031
145 DERMATITIS ALLERGIC 39 0.0031
146 GASTROINTESTINAL HAEMORRHAGE 259 0.0031
147 TUBULOINTERSTITIAL NEPHRITIS 58 0.0031
148 LIMB INJURY 84 0.0031
149 MALABSORPTION 16 0.0031
150 LEFT VENTRICULAR HYPERTROPHY 13 0.0030
151 UPPER-AIRWAY COUGH SYNDROME 25 0.0030
152 GALLBLADDER DISORDER 54 0.0030
153 GASTROENTERITIS 44 0.0030
154 ATELECTASIS 29 0.0030
155 GASTROINTESTINAL MOTILITY DISORDER 16 0.0030
156 CHOLELITHIASIS 98 0.0030
157 BLOOD SODIUM DECREASED 56 0.0030
158 SEASONAL ALLERGY 42 0.0030
159 CHOLECYSTITIS 35 0.0029
160 PHLEBITIS 15 0.0029
161 OSTEOPOROSIS 120 0.0029
162 SPLENOMEGALY 34 0.0029
163 RENAL CYST 23 0.0029
164 GASTRIC INFECTION 11 0.0029
165 HAEMATOCRIT DECREASED 57 0.0029
166 BLOOD UREA INCREASED 48 0.0029
167 TRANSFUSION 30 0.0029
168 INFUSION RELATED REACTION 189 0.0028
169 HYPOPHOSPHATAEMIA 21 0.0028
170 CONSTIPATION 619 0.0028
171 PNEUMOTHORAX 45 0.0028
172 STAPHYLOCOCCAL SEPSIS 14 0.0028
173 CLOSTRIDIUM DIFFICILE COLITIS 30 0.0028
174 FOOT OPERATION 14 0.0028
175 DECUBITUS ULCER 23 0.0028
176 GRAFT VERSUS HOST DISEASE 20 0.0028
177 FAECES DISCOLOURED 60 0.0028
178 AZOTAEMIA 11 0.0028
179 TOOTH ABSCESS 28 0.0027
180 INSURANCE ISSUE 42 0.0027
181 BLOOD POTASSIUM DECREASED 82 0.0027
182 EAR PAIN 53 0.0027
183 ABDOMINAL PAIN 633 0.0027
184 CELLULITIS 137 0.0027
185 CARDIOMEGALY 33 0.0027
186 PRODUCT ADMINISTRATION INTERRUPTED 21 0.0027
187 HYPOPHAGIA 68 0.0027
188 ARTERIOSCLEROSIS 25 0.0027
189 FEBRILE NEUTROPENIA 175 0.0026
190 INTERNAL HAEMORRHAGE 30 0.0026
191 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 137 0.0026
192 CARDIAC VALVE DISEASE 15 0.0026
193 TUMOUR LYSIS SYNDROME 23 0.0026
194 ANAEMIA 497 0.0026
195 PRODUCT USE COMPLAINT 41 0.0026
196 CONCOMITANT DISEASE AGGRAVATED 16 0.0026
197 ABSCESS LIMB 11 0.0026
198 FACIAL PAIN 23 0.0026
199 HEPATIC ENCEPHALOPATHY 24 0.0026
200 PRODUCTIVE COUGH 122 0.0026
201 JOINT DISLOCATION 27 0.0026
202 ANHEDONIA 67 0.0025
203 GASTROINTESTINAL PAIN 28 0.0025
204 INTESTINAL ISCHAEMIA 14 0.0025
205 BENIGN PROSTATIC HYPERPLASIA 13 0.0025
206 BRONCHITIS 186 0.0025
207 ENTERITIS 16 0.0025
208 ANGIOPATHY 14 0.0025
209 SKIN INFECTION 28 0.0025
210 INFUSION SITE ERYTHEMA 21 0.0025
211 UPPER RESPIRATORY TRACT INFECTION 115 0.0025
212 PROCTALGIA 16 0.0025
213 RENAL FAILURE CHRONIC 19 0.0025
214 FEEDING DISORDER 50 0.0025
215 MAJOR DEPRESSION 18 0.0025
216 PANCREATIC DISORDER 12 0.0024
217 LOWER GASTROINTESTINAL HAEMORRHAGE 18 0.0024
218 VENOOCCLUSIVE LIVER DISEASE 12 0.0024
219 DEHYDRATION 322 0.0024
220 DYSPHAGIA 229 0.0024
221 SLEEP APNOEA SYNDROME 46 0.0024
222 INFUSION SITE EXTRAVASATION 15 0.0024
223 HYPERNATRAEMIA 12 0.0024
224 EAR DISORDER 11 0.0024
225 FLUID INTAKE REDUCED 12 0.0024
226 BLOOD CALCIUM INCREASED 21 0.0024
227 DIVERTICULUM 17 0.0024
228 TRICUSPID VALVE INCOMPETENCE 19 0.0024
229 MUSCULOSKELETAL CHEST PAIN 37 0.0024
230 SPINAL OSTEOARTHRITIS 21 0.0024
231 PRODUCT SOLUBILITY ABNORMAL 12 0.0024
232 BLOOD ALKALINE PHOSPHATASE INCREASED 59 0.0024
233 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 169 0.0024
234 TASTE DISORDER 48 0.0024
235 CHOLECYSTECTOMY 27 0.0024
236 DYSPNOEA EXERTIONAL 89 0.0024
237 INTESTINAL OBSTRUCTION 89 0.0024
238 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 12 0.0024
239 PULMONARY MASS 35 0.0023
240 ACUTE RESPIRATORY FAILURE 45 0.0023
241 BODY TEMPERATURE DECREASED 23 0.0023
242 HOSPICE CARE 23 0.0023
243 SPUTUM DISCOLOURED 22 0.0023
244 BLOOD URINE PRESENT 44 0.0023
245 OXYGEN SATURATION DECREASED 130 0.0023
246 WEIGHT DECREASED 645 0.0023
247 HAEMORRHOIDS 45 0.0023
248 NOCTURIA 28 0.0023
249 PETECHIAE 24 0.0023
250 ORTHOSTATIC HYPOTENSION 40 0.0023
251 HYPOKALAEMIA 106 0.0023
252 POLYP 15 0.0023
253 ABDOMINAL PAIN UPPER 469 0.0023
254 LUNG INFILTRATION 20 0.0023
255 BLOOD PRESSURE SYSTOLIC INCREASED 44 0.0023
256 CHOKING 44 0.0023
257 THROAT IRRITATION 101 0.0022
258 BODY HEIGHT DECREASED 24 0.0022
259 POST-TRAUMATIC STRESS DISORDER 15 0.0022
260 NASAL DRYNESS 14 0.0022
261 LIGAMENT SPRAIN 22 0.0022
262 MULTIPLE INJURIES 14 0.0022
263 HAEMOGLOBIN DECREASED 227 0.0022
264 PULMONARY ARTERIAL HYPERTENSION 32 0.0022
265 TENDERNESS 23 0.0022
266 DIFFUSE LARGE B-CELL LYMPHOMA 17 0.0022
267 WEIGHT FLUCTUATION 23 0.0022
268 OBESITY 35 0.0022
269 CARDIAC MURMUR 19 0.0022
270 CANDIDA INFECTION 37 0.0022
271 ORAL PAIN 49 0.0022
272 CORONARY ARTERY OCCLUSION 30 0.0022
273 HYPERCALCAEMIA 27 0.0022
274 HEPATIC CIRRHOSIS 41 0.0022
275 CARDIAC PACEMAKER INSERTION 13 0.0022
276 PNEUMONIA BACTERIAL 20 0.0022
277 PHARYNGITIS 27 0.0022
278 HYPERLIPIDAEMIA 26 0.0022
279 DRUG LEVEL BELOW THERAPEUTIC 12 0.0022
280 HYPERKERATOSIS 12 0.0022
281 PROTHROMBIN TIME PROLONGED 13 0.0022
282 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 11 0.0022
283 HERNIA 42 0.0022
284 GAMMA-GLUTAMYLTRANSFERASE INCREASED 48 0.0022
285 PULMONARY HYPERTENSION 45 0.0022
286 HYPERTRANSAMINASAEMIA 15 0.0022
287 AMMONIA INCREASED 11 0.0022
288 TOOTHACHE 39 0.0022
289 MUSCULOSKELETAL DISCOMFORT 37 0.0021
290 RIB FRACTURE 44 0.0021
291 HEPATOMEGALY 21 0.0021
292 ANKLE FRACTURE 33 0.0021
293 MULTIPLE FRACTURES 35 0.0021
294 POOR VENOUS ACCESS 22 0.0021
295 TOOTH INFECTION 28 0.0021
296 GOUT 38 0.0021
297 URINARY TRACT INFECTION 360 0.0021
298 PULMONARY THROMBOSIS 23 0.0021
299 STENT PLACEMENT 17 0.0021
300 CARDIAC FAILURE ACUTE 14 0.0021
301 NEUROLOGICAL SYMPTOM 12 0.0021
302 RED BLOOD CELL COUNT DECREASED 60 0.0021
303 DIVERTICULITIS 58 0.0021
304 RESTLESS LEGS SYNDROME 38 0.0021
305 SHOCK HAEMORRHAGIC 17 0.0021
306 LIPASE INCREASED 16 0.0021
307 HYPERCHOLESTEROLAEMIA 20 0.0021
308 SINUSITIS 212 0.0021
309 OROPHARYNGEAL PAIN 191 0.0021
310 PHOTOPSIA 13 0.0021
311 PANCREATITIS ACUTE 46 0.0020
312 DECREASED IMMUNE RESPONSIVENESS 20 0.0020
313 RESPIRATORY TRACT INFECTION 53 0.0020
314 CARDIOMYOPATHY 30 0.0020
315 EAR INFECTION 54 0.0020
316 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 12 0.0020
317 FLUID RETENTION 103 0.0020
318 ARTHROPOD BITE 15 0.0020
319 BIPOLAR DISORDER 22 0.0020
320 SKIN LACERATION 22 0.0020
321 EATING DISORDER 43 0.0020
322 BLOOD ALBUMIN DECREASED 16 0.0020
323 CLOSTRIDIUM DIFFICILE INFECTION 44 0.0020
324 INTERVERTEBRAL DISC PROTRUSION 44 0.0020
325 ABDOMINAL DISTENSION 210 0.0020
326 CARDIAC FLUTTER 13 0.0020
327 ASCITES 59 0.0020
328 IRRITABLE BOWEL SYNDROME 43 0.0020
329 DYSURIA 73 0.0020
330 GASTRIC DISORDER 68 0.0020
331 ASPERGILLUS INFECTION 13 0.0020
332 PULMONARY CONGESTION 26 0.0020
333 EXOSTOSIS 18 0.0020
334 PYELONEPHRITIS 17 0.0020
335 BLOOD PRESSURE ABNORMAL 39 0.0020
336 APPETITE DISORDER 13 0.0020
337 BOWEL MOVEMENT IRREGULARITY 15 0.0020
338 SKIN HAEMORRHAGE 29 0.0020
339 BLOOD CALCIUM DECREASED 22 0.0020
340 OEDEMA 106 0.0020
341 CORONARY ARTERY DISEASE 59 0.0019
342 MITRAL VALVE INCOMPETENCE 22 0.0019
343 PANIC REACTION 14 0.0019
344 BACTERIAL INFECTION 36 0.0019
345 INTERNATIONAL NORMALISED RATIO INCREASED 55 0.0019
346 BLOOD PRESSURE FLUCTUATION 46 0.0019
347 SECRETION DISCHARGE 24 0.0019
348 CYSTITIS 61 0.0019
349 RESPIRATORY RATE INCREASED 17 0.0019
350 DENTAL CARIES 21 0.0019
351 NASAL DISCOMFORT 15 0.0019
352 HEPATIC FAILURE 57 0.0019
353 DRY MOUTH 153 0.0019
354 KIDNEY INFECTION 37 0.0019
355 NECK PAIN 105 0.0019
356 HAIR GROWTH ABNORMAL 13 0.0019
357 DECREASED APPETITE 435 0.0019
358 ROTATOR CUFF SYNDROME 24 0.0019
359 SINUS DISORDER 37 0.0019
360 FORMICATION 13 0.0019
361 SLUGGISHNESS 19 0.0019
362 FUNGAL INFECTION 62 0.0019
363 INTENTIONAL DOSE OMISSION 53 0.0019
364 GENERALISED OEDEMA 23 0.0019
365 CARPAL TUNNEL SYNDROME 26 0.0019
366 RIGHT VENTRICULAR FAILURE 13 0.0019
367 BACTERAEMIA 22 0.0019
368 GASTROINTESTINAL DISORDER 166 0.0019
369 NAUSEA 1466 0.0019
370 CHEST PAIN 343 0.0019
371 BLOOD PRESSURE DECREASED 123 0.0018
372 INCREASED TENDENCY TO BRUISE 17 0.0018
373 BLOOD POTASSIUM INCREASED 30 0.0018
374 HYPOTHYROIDISM 59 0.0018
375 PRODUCT TASTE ABNORMAL 25 0.0018
376 TROPONIN INCREASED 14 0.0018
377 SEPSIS 205 0.0018
378 WRIST FRACTURE 22 0.0018
379 HAND FRACTURE 13 0.0018
380 PNEUMONIA 594 0.0018
381 HEAD INJURY 58 0.0018
382 PRODUCT DISTRIBUTION ISSUE 17 0.0018
383 ARTHRITIS 144 0.0018
384 BLOOD LACTATE DEHYDROGENASE INCREASED 29 0.0018
385 URINE OUTPUT DECREASED 16 0.0018
386 ABDOMINAL DISCOMFORT 307 0.0018
387 RETCHING 39 0.0018
388 RESPIRATORY TRACT CONGESTION 29 0.0018
389 BONE DISORDER 33 0.0018
390 FIBROMYALGIA 44 0.0018
391 IMPAIRED QUALITY OF LIFE 26 0.0018
392 OBSTRUCTIVE AIRWAYS DISORDER 20 0.0018
393 HYPOMAGNESAEMIA 25 0.0018
394 SPINAL DISORDER 17 0.0018
395 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
396 JOINT INJURY 38 0.0018
397 COLITIS ISCHAEMIC 12 0.0018
398 PANCREATITIS 94 0.0018
399 VOMITING 836 0.0018
400 DISSEMINATED INTRAVASCULAR COAGULATION 25 0.0018
401 HEART RATE DECREASED 62 0.0018
402 GLAUCOMA 34 0.0018
403 ABNORMAL LOSS OF WEIGHT 12 0.0018
404 VENTRICULAR TACHYCARDIA 29 0.0018
405 PHARYNGITIS STREPTOCOCCAL 19 0.0018
406 PSEUDOMONAS INFECTION 15 0.0017
407 FLATULENCE 99 0.0017
408 FULL BLOOD COUNT DECREASED 35 0.0017
409 HYPOXIA 61 0.0017
410 NEPHROLITHIASIS 79 0.0017
411 BACK DISORDER 28 0.0017
412 PULMONARY FIBROSIS 33 0.0017
413 BACK PAIN 397 0.0017
414 AORTIC ANEURYSM 13 0.0017
415 ILLNESS 176 0.0017
416 GROIN PAIN 15 0.0017
417 GASTRIC CANCER 43 0.0017
418 ATRIAL FIBRILLATION 165 0.0017
419 PLEURAL EFFUSION 103 0.0017
420 DIALYSIS 24 0.0017
421 PNEUMONITIS 46 0.0017
422 DEVICE RELATED INFECTION 26 0.0017
423 PLATELET COUNT INCREASED 22 0.0017
424 NEURALGIA 41 0.0017
425 FOOD ALLERGY 13 0.0017
426 DYSPHONIA 98 0.0017
427 BONE PAIN 98 0.0017
428 HYPOALBUMINAEMIA 13 0.0017
429 GASTROENTERITIS VIRAL 30 0.0017
430 MULTIPLE ALLERGIES 13 0.0017
431 EPISTAXIS 124 0.0017
432 SINUS BRADYCARDIA 16 0.0017
433 LOCALISED INFECTION 40 0.0017
434 FAECES SOFT 12 0.0016
435 DIZZINESS POSTURAL 16 0.0016
436 LIVER DISORDER 73 0.0016
437 MASS 23 0.0016
438 PERICARDIAL EFFUSION 38 0.0016
439 DIARRHOEA 1057 0.0016
440 COUGH 459 0.0016
441 FOOT FRACTURE 31 0.0016
442 ATRIAL FLUTTER 13 0.0016
443 BLOOD BILIRUBIN INCREASED 44 0.0016
444 SENSITIVE SKIN 12 0.0016
445 MUSCLE STRAIN 14 0.0016
446 HYSTERECTOMY 14 0.0016
447 ACTIVITIES OF DAILY LIVING IMPAIRED 32 0.0016
448 STOMATITIS 98 0.0016
449 INABILITY TO AFFORD MEDICATION 16 0.0016
450 HEPATIC STEATOSIS 30 0.0016
451 STAPHYLOCOCCAL INFECTION 53 0.0016
452 MUSCLE TWITCHING 37 0.0016
453 HYDRONEPHROSIS 12 0.0016
454 FLANK PAIN 15 0.0016
455 METASTASES TO LIVER 28 0.0016
456 LYMPHOCYTE COUNT DECREASED 28 0.0016
457 ORAL DISCOMFORT 22 0.0016
458 ASPARTATE AMINOTRANSFERASE INCREASED 84 0.0016
459 ERYTHEMA 325 0.0016
460 TOXIC EPIDERMAL NECROLYSIS 24 0.0016
461 FLUID OVERLOAD 23 0.0016
462 DERMATITIS CONTACT 18 0.0016
463 PLATELET COUNT DECREASED 168 0.0016
464 EXTRASYSTOLES 11 0.0016
465 STEVENS-JOHNSON SYNDROME 35 0.0016
466 TRANSAMINASES INCREASED 35 0.0016
467 PYREXIA 544 0.0016
468 HYPERTHERMIA 12 0.0016
469 MULTI-ORGAN FAILURE 27 0.0016
470 PNEUMONIA ASPIRATION 39 0.0016
471 CONTUSION 150 0.0016
472 SINUS CONGESTION 21 0.0016
473 ANOREXIA 20 0.0016
474 WHEEZING 92 0.0015
475 PAIN 952 0.0015
476 ELECTROLYTE IMBALANCE 18 0.0015
477 ASTHENIA 582 0.0015
478 CARDIAC FAILURE CONGESTIVE 124 0.0015
479 OEDEMA PERIPHERAL 188 0.0015
480 PELVIC FRACTURE 12 0.0015
481 FALL 512 0.0015
482 GASTROINTESTINAL INFLAMMATION 12 0.0015
483 PERIPHERAL SWELLING 236 0.0015
484 SKIN DISORDER 51 0.0015
485 MOVEMENT DISORDER 49 0.0015
486 HYPOAESTHESIA ORAL 23 0.0015
487 FACIAL PARALYSIS 13 0.0015
488 PANCYTOPENIA 85 0.0015
489 GLOSSODYNIA 34 0.0015
490 NERVE COMPRESSION 14 0.0015
491 THROAT TIGHTNESS 41 0.0015
492 FULL BLOOD COUNT ABNORMAL 16 0.0015
493 FISTULA 17 0.0015
494 BLADDER DISORDER 15 0.0015
495 HAEMOPTYSIS 42 0.0015
496 CHEST DISCOMFORT 154 0.0015
497 POLYNEUROPATHY 18 0.0015
498 HYPERSOMNIA 43 0.0015
499 ERUCTATION 29 0.0015
500 BLOOD DISORDER 12 0.0015
501 BLOOD TEST ABNORMAL 21 0.0015
502 HEART RATE INCREASED 148 0.0015
503 SEPTIC SHOCK 65 0.0015
504 HAEMATURIA 51 0.0015
505 HEADACHE 933 0.0015
506 POLLAKIURIA 62 0.0015
507 LEUKAEMIA 14 0.0015
508 HYPOTENSION 297 0.0015
509 SKIN DISCOLOURATION 68 0.0015
510 SINUS TACHYCARDIA 21 0.0015
511 MENTAL STATUS CHANGES 41 0.0015
512 FEELING COLD 41 0.0015
513 MOUTH ULCERATION 31 0.0015
514 SKIN ULCER 38 0.0015
515 SURGERY 86 0.0015
516 HELICOBACTER INFECTION 15 0.0015
517 DYSPNOEA 824 0.0015
518 SPINAL COMPRESSION FRACTURE 12 0.0014
519 ALANINE AMINOTRANSFERASE INCREASED 89 0.0014
520 NASAL CONGESTION 85 0.0014
521 THERAPY NON-RESPONDER 65 0.0014
522 MALAISE 634 0.0014
523 VENTRICULAR EXTRASYSTOLES 15 0.0014
524 SCIATICA 23 0.0014
525 VIRAL INFECTION 48 0.0014
526 OROPHARYNGEAL DISCOMFORT 13 0.0014
527 RENAL DISORDER 67 0.0014
528 COELIAC DISEASE 14 0.0014
529 BLOOD PRESSURE INCREASED 218 0.0014
530 EYE HAEMORRHAGE 19 0.0014
531 BODY TEMPERATURE INCREASED 29 0.0014
532 CONCUSSION 11 0.0014
533 WHITE BLOOD CELL COUNT DECREASED 154 0.0014
534 MUSCLE TIGHTNESS 23 0.0014
535 INFECTION 205 0.0014
536 DIABETES MELLITUS INADEQUATE CONTROL 25 0.0014
537 UROSEPSIS 13 0.0014
538 ANXIETY 401 0.0014
539 PULMONARY OEDEMA 63 0.0014
540 POST PROCEDURAL COMPLICATION 27 0.0014
541 VITAMIN D DECREASED 12 0.0014
542 MIGRAINE 134 0.0014
543 SCAB 16 0.0014
544 FEELING HOT 86 0.0014
545 DEPRESSION 319 0.0014
546 RASH MACULAR 49 0.0014
547 MICTURITION URGENCY 16 0.0014
548 ANGINA PECTORIS 40 0.0014
549 MUSCLE SPASMS 256 0.0014
550 TOOTH DISORDER 31 0.0014
551 MIDDLE INSOMNIA 26 0.0014
552 DECREASED ACTIVITY 15 0.0014
553 ACUTE MYOCARDIAL INFARCTION 41 0.0014
554 EMPHYSEMA 14 0.0014
555 WHITE BLOOD CELL COUNT INCREASED 53 0.0014
556 HYPOKINESIA 20 0.0014
557 MEMORY IMPAIRMENT 189 0.0014
558 ASPIRATION 15 0.0014
559 BLOOD GLUCOSE FLUCTUATION 15 0.0014
560 TOOTH EXTRACTION 17 0.0014
561 INITIAL INSOMNIA 14 0.0014
562 FRUSTRATION TOLERANCE DECREASED 11 0.0014
563 FATIGUE 1058 0.0014
564 PRESYNCOPE 33 0.0014
565 DEEP VEIN THROMBOSIS 88 0.0014
566 LUNG INFECTION 21 0.0014
567 TARDIVE DYSKINESIA 38 0.0013
568 RHINORRHOEA 87 0.0013
569 CATARACT 80 0.0013
570 DRY EYE 67 0.0013
571 PRODUCT DOSE OMISSION IN ERROR 38 0.0013
572 QUALITY OF LIFE DECREASED 18 0.0013
573 NIGHT SWEATS 43 0.0013
574 RENAL IMPAIRMENT 112 0.0013
575 PHARYNGEAL SWELLING 13 0.0013
576 THERAPEUTIC RESPONSE SHORTENED 44 0.0013
577 BURNING SENSATION 93 0.0013
578 LEUKOCYTOSIS 24 0.0013
579 DELIRIUM 46 0.0013
580 VITREOUS FLOATERS 13 0.0013
581 CHILLS 155 0.0013
582 RENAL FAILURE ACUTE 56 0.0013
583 LOWER RESPIRATORY TRACT INFECTION 60 0.0013
584 INFLUENZA 147 0.0013
585 SLEEP DISORDER 93 0.0013
586 ABSCESS 21 0.0013
587 HYPOAESTHESIA 197 0.0013
588 DISABILITY 26 0.0013
589 METABOLIC ACIDOSIS 42 0.0013
590 UPPER LIMB FRACTURE 26 0.0013
591 MUSCULOSKELETAL PAIN 68 0.0013
592 THYROID DISORDER 20 0.0013
593 DIZZINESS 646 0.0013
594 ROAD TRAFFIC ACCIDENT 54 0.0013
595 INTENTIONAL PRODUCT USE ISSUE 113 0.0013
596 APHONIA 18 0.0013
597 HYPERTENSION 273 0.0013
598 BACK INJURY 14 0.0013
599 DISORIENTATION 51 0.0013
600 LUNG DISORDER 63 0.0013
601 APPENDICITIS 12 0.0013
602 DISEASE PROGRESSION 152 0.0013
603 TACHYCARDIA 114 0.0013
604 DYSKINESIA 52 0.0013
605 DEVICE OCCLUSION 18 0.0013
606 ANURIA 11 0.0013
607 RESPIRATORY FAILURE 93 0.0013
608 NASOPHARYNGITIS 235 0.0013
609 TRANSIENT ISCHAEMIC ATTACK 43 0.0013
610 COVID-19 PNEUMONIA 15 0.0013
611 OSTEOMYELITIS 23 0.0013
612 EAR DISCOMFORT 13 0.0013
613 BLOOD CHOLESTEROL INCREASED 59 0.0013
614 LIMB DISCOMFORT 39 0.0013
615 ASTHMA 142 0.0013
616 INCREASED APPETITE 24 0.0013
617 HYPERKALAEMIA 44 0.0013
618 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
619 SEROTONIN SYNDROME 24 0.0012
620 PALLOR 34 0.0012
621 URINARY INCONTINENCE 37 0.0012
622 CARDIAC FAILURE 100 0.0012
623 THROMBOSIS 100 0.0012
624 HYPONATRAEMIA 70 0.0012
625 LOSS OF CONSCIOUSNESS 159 0.0012
626 CHROMATURIA 28 0.0012
627 EYE INFECTION 14 0.0012
628 COMPLICATION ASSOCIATED WITH DEVICE 18 0.0012
629 SYNCOPE 124 0.0012
630 MOBILITY DECREASED 89 0.0012
631 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 21 0.0012
632 SCRATCH 13 0.0012
633 RESPIRATORY DISTRESS 34 0.0012
634 THERAPY INTERRUPTED 88 0.0012
635 INJURY 86 0.0012
636 ARTHROPATHY 68 0.0012
637 ENCEPHALOPATHY 30 0.0012
638 BREAST PAIN 13 0.0012
639 HERPES ZOSTER 70 0.0012
640 BEDRIDDEN 16 0.0012
641 HEREDITARY ANGIOEDEMA 13 0.0012
642 NEUROPATHY PERIPHERAL 115 0.0012
643 PAIN IN EXTREMITY 356 0.0012
644 EXTRAPYRAMIDAL DISORDER 30 0.0012
645 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 58 0.0012
646 EYE PAIN 68 0.0012
647 POST PROCEDURAL HAEMORRHAGE 14 0.0012
648 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 28 0.0012
649 HAEMATOMA 31 0.0012
650 ARTHRALGIA 496 0.0012
651 BLOOD GLUCOSE ABNORMAL 22 0.0012
652 KNEE ARTHROPLASTY 25 0.0012
653 WOUND INFECTION 13 0.0012
654 CARDIOGENIC SHOCK 17 0.0012
655 VERTIGO 72 0.0012
656 DRY THROAT 12 0.0012
657 HYPERGLYCAEMIA 43 0.0012
658 TOOTH FRACTURE 13 0.0012
659 HIP ARTHROPLASTY 18 0.0012
660 URINARY RETENTION 39 0.0012
661 WEIGHT INCREASED 261 0.0012
662 PAIN IN JAW 33 0.0012
663 DYSSTASIA 34 0.0012
664 INFLAMMATION 60 0.0012
665 MUSCULAR WEAKNESS 132 0.0012
666 HEPATITIS C 14 0.0012
667 TYPE 2 DIABETES MELLITUS 39 0.0012
668 CONFUSIONAL STATE 187 0.0012
669 TREMOR 192 0.0012
670 SWELLING 108 0.0012
671 HEPATIC FUNCTION ABNORMAL 43 0.0012
672 GAIT DISTURBANCE 220 0.0011
673 PRODUCT PRESCRIBING ISSUE 25 0.0011
674 DRUG EFFECT LESS THAN EXPECTED 17 0.0011
675 DIABETES MELLITUS 87 0.0011
676 CONDITION AGGRAVATED 347 0.0011
677 DRUG INTERACTION 181 0.0011
678 COAGULOPATHY 19 0.0011
679 COVID-19 200 0.0011
680 GAIT INABILITY 38 0.0011
681 SWELLING FACE 74 0.0011
682 SARS-COV-2 TEST POSITIVE 15 0.0011
683 INCONTINENCE 12 0.0011
684 BALANCE DISORDER 98 0.0011
685 RENAL PAIN 12 0.0011
686 BONE LOSS 17 0.0011
687 PRODUCT DOSE OMISSION ISSUE 332 0.0011
688 PLASMA CELL MYELOMA 44 0.0011
689 AGEUSIA 28 0.0011
690 VASCULITIS 13 0.0011
691 CIRCULATORY COLLAPSE 19 0.0011
692 FEAR 30 0.0011
693 DISCOMFORT 68 0.0011
694 LETHARGY 64 0.0011
695 THERAPY CESSATION 57 0.0011
696 WOUND 31 0.0011
697 DEAFNESS 29 0.0011
698 HEART RATE IRREGULAR 25 0.0011
699 MYELODYSPLASTIC SYNDROME 16 0.0011
700 MUSCULOSKELETAL DISORDER 21 0.0011
701 JOINT SWELLING 133 0.0011
702 LYMPHADENOPATHY 39 0.0011
703 HOSPITALISATION 169 0.0011
704 ATAXIA 13 0.0011
705 LOWER LIMB FRACTURE 21 0.0011
706 ACCIDENT 13 0.0011
707 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 196 0.0011
708 BLOOD CREATININE INCREASED 71 0.0011
709 BONE DENSITY DECREASED 34 0.0011
710 BRAIN FOG 17 0.0011
711 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
712 NEUROTOXICITY 19 0.0011
713 MYALGIA 183 0.0011
714 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
715 IMMUNODEFICIENCY 16 0.0011
716 DRUG ERUPTION 19 0.0011
717 ADRENAL INSUFFICIENCY 13 0.0011
718 UNEVALUABLE EVENT 81 0.0011
719 EMOTIONAL DISORDER 33 0.0011
720 HALLUCINATION, AUDITORY 17 0.0011
721 RESPIRATORY DISORDER 32 0.0011
722 PALPITATIONS 125 0.0011
723 FEELING ABNORMAL 253 0.0011
724 BLOOD COUNT ABNORMAL 16 0.0011
725 INSOMNIA 280 0.0011
726 THERAPEUTIC PRODUCT EFFECT DECREASED 47 0.0010
727 SEIZURE 121 0.0010
728 CRYING 38 0.0010
729 TINNITUS 48 0.0010
730 HAIR COLOUR CHANGES 13 0.0010
731 HEPATIC ENZYME INCREASED 71 0.0010
732 PRODUCT PHYSICAL ISSUE 21 0.0010
733 INTERSTITIAL LUNG DISEASE 50 0.0010
734 LIVER FUNCTION TEST ABNORMAL 30 0.0010
735 HYPOGLYCAEMIA 50 0.0010
736 VISION BLURRED 141 0.0010
737 HYPERHIDROSIS 132 0.0010
738 CONJUNCTIVITIS 19 0.0010
739 SKIN FISSURES 20 0.0010
740 OFF LABEL USE 895 0.0010
741 POOR QUALITY SLEEP 22 0.0010
742 SKIN CANCER 22 0.0010
743 HOT FLUSH 77 0.0010
744 RHEUMATOID ARTHRITIS 116 0.0010
745 EYE SWELLING 38 0.0010
746 COLD SWEAT 18 0.0010
747 HEAD DISCOMFORT 18 0.0010
748 MALIGNANT NEOPLASM PROGRESSION 104 0.0010
749 PANIC ATTACK 37 0.0010
750 BLISTER 57 0.0010
751 RASH PRURITIC 55 0.0010
752 NERVOUSNESS 53 0.0010
753 FLUSHING 103 0.0010
754 SPEECH DISORDER 53 0.0010
755 MENTAL DISORDER 44 0.0010
756 PRODUCT DOSE OMISSION 66 0.0010
757 PHOTOPHOBIA 19 0.0010
758 VISUAL IMPAIRMENT 125 0.0010
759 HALLUCINATION 76 0.0010
760 COLON CANCER 15 0.0010
761 HAEMORRHAGE 105 0.0010
762 DIPLOPIA 26 0.0010
763 PULMONARY EMBOLISM 95 0.0010
764 MENTAL IMPAIRMENT 24 0.0010
765 RASH MACULO-PAPULAR 22 0.0010
766 PARANOIA 17 0.0010
767 PSYCHOTIC DISORDER 29 0.0010
768 THROMBOCYTOPENIA 109 0.0010
769 LOCAL SWELLING 17 0.0010
770 SPINAL OPERATION 12 0.0010
771 ORAL HERPES 19 0.0010
772 CARDIAC DISORDER 91 0.0010
773 PHOTOSENSITIVITY REACTION 16 0.0010
774 TREATMENT NONCOMPLIANCE 53 0.0010
775 AMNESIA 63 0.0010
776 DEMENTIA 27 0.0010
777 THINKING ABNORMAL 18 0.0010
778 INJECTION SITE SWELLING 74 0.0010
779 BASAL CELL CARCINOMA 15 0.0010
780 UVEITIS 13 0.0010
781 NEUTROPHIL COUNT DECREASED 39 0.0010
782 SOMNOLENCE 192 0.0010
783 JOINT STIFFNESS 25 0.0010
784 THIRST 17 0.0010
785 BRAIN OEDEMA 12 0.0009
786 ABDOMINAL PAIN LOWER 24 0.0009
787 FACE OEDEMA 16 0.0009
788 SPINAL FRACTURE 19 0.0009
789 SKIN LESION 26 0.0009
790 HALLUCINATION, VISUAL 20 0.0009
791 MUSCLE ATROPHY 12 0.0009
792 PROTEINURIA 18 0.0009
793 HUNGER 13 0.0009
794 HIP FRACTURE 30 0.0009
795 LIVER FUNCTION TEST INCREASED 20 0.0009
796 UNRESPONSIVE TO STIMULI 24 0.0009
797 DYSARTHRIA 35 0.0009
798 HYPOACUSIS 40 0.0009
799 EMOTIONAL DISTRESS 111 0.0009
800 IMPAIRED HEALING 30 0.0009
801 SUBDURAL HAEMATOMA 13 0.0009
802 BURSITIS 11 0.0009
803 LYMPHOMA 14 0.0009
804 ILL-DEFINED DISORDER 55 0.0009
805 BRADYCARDIA 48 0.0009
806 PARAESTHESIA 142 0.0009
807 SYSTEMIC LUPUS ERYTHEMATOSUS 32 0.0009
808 ACUTE MYELOID LEUKAEMIA 14 0.0009
809 HEPATOTOXICITY 20 0.0009
810 CYTOKINE RELEASE SYNDROME 18 0.0009
811 NERVOUS SYSTEM DISORDER 28 0.0009
812 CARDIAC ARREST 74 0.0009
813 JAUNDICE 24 0.0009
814 CYANOSIS 14 0.0009
815 DEPRESSED MOOD 47 0.0009
816 CYST 11 0.0009
817 TACHYPNOEA 12 0.0009
818 EYE DISORDER 29 0.0009
819 PRODUCT PRESCRIBING ERROR 21 0.0009
820 C-REACTIVE PROTEIN INCREASED 32 0.0009
821 RASH 383 0.0009
822 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
823 THERAPEUTIC RESPONSE UNEXPECTED 39 0.0009
824 GENERAL PHYSICAL HEALTH DETERIORATION 100 0.0009
825 APHASIA 26 0.0009
826 CEREBRAL INFARCTION 21 0.0009
827 DERMATITIS 18 0.0009
828 BLOOD GLUCOSE DECREASED 41 0.0009
829 NEUTROPENIA 116 0.0009
830 METASTASES TO BONE 14 0.0009
831 FRACTURE 16 0.0008
832 PRURITUS 324 0.0008
833 PRODUCT USE IN UNAPPROVED INDICATION 208 0.0008
834 EYE IRRITATION 48 0.0008
835 DIABETIC KETOACIDOSIS 20 0.0008
836 SWOLLEN TONGUE 26 0.0008
837 DRUG INTOLERANCE 80 0.0008
838 HEMIPARESIS 14 0.0008
839 NEEDLE ISSUE 24 0.0008
840 ARRHYTHMIA 39 0.0008
841 RESTLESSNESS 30 0.0008
842 PRODUCT USE ISSUE 154 0.0008
843 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
844 DRY SKIN 109 0.0008
845 INTENTIONAL PRODUCT MISUSE 71 0.0008
846 CEREBRAL HAEMORRHAGE 29 0.0008
847 DYSGEUSIA 60 0.0008
848 DRUG TOXICITY 11 0.0008
849 AGRANULOCYTOSIS 15 0.0008
850 SNEEZING 18 0.0008
851 LACRIMATION INCREASED 24 0.0008
852 ALOPECIA 156 0.0008
853 HYPOCALCAEMIA 15 0.0008
854 CARDIO-RESPIRATORY ARREST 33 0.0008
855 BONE MARROW FAILURE 16 0.0008
856 BLINDNESS 32 0.0008
857 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
858 SHOCK 18 0.0008
859 HEPATITIS 20 0.0008
860 NIGHTMARE 27 0.0008
861 LABORATORY TEST ABNORMAL 23 0.0008
862 INFLUENZA LIKE ILLNESS 64 0.0008
863 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22 0.0008
864 SKIN EXFOLIATION 65 0.0008
865 INJECTION SITE BRUISING 61 0.0008
866 SCAR 13 0.0008
867 APATHY 11 0.0008
868 MUSCULOSKELETAL STIFFNESS 66 0.0008
869 GLYCOSYLATED HAEMOGLOBIN INCREASED 19 0.0008
870 PRESCRIBED UNDERDOSE 15 0.0008
871 COGNITIVE DISORDER 35 0.0007
872 PRODUCT ADMINISTRATION ERROR 15 0.0007
873 LEUKOPENIA 37 0.0007
874 BLOOD GLUCOSE INCREASED 139 0.0007
875 OCULAR HYPERAEMIA 35 0.0007
876 LIVER INJURY 18 0.0007
877 MYOCARDIAL INFARCTION 127 0.0007
878 SEDATION 19 0.0007
879 VISUAL ACUITY REDUCED 24 0.0007
880 AGITATION 53 0.0007
881 NEOPLASM PROGRESSION 25 0.0007
882 ECZEMA 37 0.0007
883 CEREBROVASCULAR ACCIDENT 119 0.0007
884 ELECTROCARDIOGRAM QT PROLONGED 25 0.0007
885 DISEASE RECURRENCE 33 0.0007
886 PRURITUS GENERALISED 15 0.0007
887 PSORIATIC ARTHROPATHY 28 0.0007
888 ABASIA 17 0.0007
889 FEELING JITTERY 13 0.0007
890 HYPERSENSITIVITY 126 0.0007
891 DRUG PRESCRIBING ERROR 13 0.0007
892 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 48 0.0007
893 NEOPLASM MALIGNANT 45 0.0007
894 RASH ERYTHEMATOUS 32 0.0007
895 CYTOMEGALOVIRUS INFECTION 11 0.0007
896 DRUG INEFFECTIVE 843 0.0006
897 OSTEONECROSIS 21 0.0006
898 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 35 0.0006
899 DEATH 548 0.0006
900 CONVULSION 36 0.0006
901 DRUG DOSE OMISSION 104 0.0006
902 PERITONITIS 13 0.0006
903 PANCREATIC CARCINOMA 18 0.0006
904 WITHDRAWAL SYNDROME 26 0.0006
905 LACTIC ACIDOSIS 20 0.0006
906 DISTURBANCE IN ATTENTION 33 0.0006
907 SUICIDAL IDEATION 56 0.0006
908 INJECTION SITE URTICARIA 15 0.0006
909 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
910 ABNORMAL BEHAVIOUR 23 0.0006
911 ADVERSE DRUG REACTION 52 0.0006
912 MEDICATION ERROR 32 0.0006
913 ACCIDENTAL OVERDOSE 21 0.0006
914 EYE PRURITUS 19 0.0006
915 IRRITABILITY 34 0.0006
916 MOOD SWINGS 18 0.0006
917 MULTIPLE SCLEROSIS 27 0.0006
918 LUNG NEOPLASM MALIGNANT 23 0.0006
919 RHABDOMYOLYSIS 23 0.0006
920 DRUG RESISTANCE 14 0.0005
921 RESPIRATORY ARREST 15 0.0005
922 URTICARIA 91 0.0005
923 EXPOSURE VIA SKIN CONTACT 14 0.0005
924 TREATMENT FAILURE 44 0.0005
925 COMA 25 0.0005
926 UNDERDOSE 38 0.0005
927 PAIN OF SKIN 14 0.0005
928 CARDIOVASCULAR DISORDER 13 0.0005
929 MULTIPLE SCLEROSIS RELAPSE 35 0.0005
930 INJECTION SITE PAIN 156 0.0005
931 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
932 ERECTILE DYSFUNCTION 13 0.0005
933 PRODUCT QUALITY ISSUE 68 0.0005
934 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
935 ANGIOEDEMA 22 0.0005
936 INJECTION SITE PRURITUS 33 0.0005
937 INJECTION SITE MASS 18 0.0005
938 INCORRECT DOSE ADMINISTERED 111 0.0005
939 PSORIASIS 63 0.0005
940 THERAPEUTIC RESPONSE DECREASED 29 0.0005
941 DRUG-INDUCED LIVER INJURY 15 0.0005
942 ADVERSE EVENT 44 0.0005
943 MOOD ALTERED 13 0.0005
944 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 96 0.0005
945 DEVICE ISSUE 42 0.0005
946 ANAPHYLACTIC SHOCK 12 0.0005
947 RASH GENERALISED 12 0.0005
948 VAGINAL HAEMORRHAGE 20 0.0005
949 INJECTION SITE RASH 14 0.0005
950 FEMUR FRACTURE 14 0.0005
951 PRODUCT SUBSTITUTION ISSUE 26 0.0005
952 SKIN BURNING SENSATION 32 0.0004
953 DRUG EFFECT DECREASED 24 0.0004
954 DRUG EFFECT INCOMPLETE 16 0.0004
955 TOXICITY TO VARIOUS AGENTS 71 0.0004
956 INCORRECT ROUTE OF DRUG ADMINISTRATION 15 0.0004
957 INJECTION SITE ERYTHEMA 51 0.0004
958 ANAPHYLACTIC REACTION 22 0.0004
959 LIP SWELLING 13 0.0004
960 WRONG TECHNIQUE IN DRUG USAGE PROCESS 14 0.0004
961 INJECTION SITE HAEMORRHAGE 30 0.0004
962 SKIN IRRITATION 17 0.0004
963 EXPIRED PRODUCT ADMINISTERED 12 0.0004
964 MYELOSUPPRESSION 13 0.0004
965 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
966 COMPLETED SUICIDE 27 0.0003
967 DERMATITIS ATOPIC 17 0.0003
968 DEVICE DISLOCATION 14 0.0003
969 AGGRESSION 16 0.0003
970 DEVICE MALFUNCTION 21 0.0003
971 SUICIDE ATTEMPT 18 0.0003
972 DEVICE BREAKAGE 12 0.0003
973 ACNE 22 0.0003
974 BREAST CANCER 27 0.0003
975 NO ADVERSE EVENT 51 0.0003
976 ACCIDENTAL EXPOSURE TO PRODUCT 28 0.0003
977 OVERDOSE 57 0.0003
978 INJECTION SITE REACTION 18 0.0003
979 DEVICE LEAKAGE 11 0.0003
980 RENAL CANCER 12 0.0003
981 PRODUCT STORAGE ERROR 21 0.0002
982 DRUG WITHDRAWAL SYNDROME 21 0.0002
983 INTENTIONAL OVERDOSE 14 0.0002
984 DRUG DEPENDENCE 29 0.0002
985 DRUG ABUSE 15 0.0002
986 EXPOSURE DURING PREGNANCY 11 0.0002
987 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
988 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001